vs
太平洋生物科学（ASMB）与PROVIDENT FINANCIAL HOLDINGS INC（PROV）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是PROVIDENT FINANCIAL HOLDINGS INC的1.1倍（$10.8M vs $9.8M），PROVIDENT FINANCIAL HOLDINGS INC净利率更高（14.6% vs -85.2%，领先99.8%），太平洋生物科学同比增速更快（57.6% vs 2.5%），PROVIDENT FINANCIAL HOLDINGS INC自由现金流更多（$1.0M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
普罗维登特金融控股公司是一家银行控股企业，通过旗下全资子公司普罗维登特储蓄银行开展业务，为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
ASMB vs PROV — 直观对比
营收规模更大
ASMB
是对方的1.1倍
$9.8M
营收增速更快
ASMB
高出55.2%
2.5%
净利率更高
PROV
高出99.8%
-85.2%
自由现金流更多
PROV
多$16.2M
$-15.2M
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $9.8M |
| 净利润 | $-9.2M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 20.8% |
| 净利率 | -85.2% | 14.6% |
| 营收同比 | 57.6% | 2.5% |
| 净利润同比 | 4.3% | 64.7% |
| 每股收益（稀释后） | $-0.72 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBPROV
| Q4 25 | — | $9.8M | ||
| Q3 25 | $10.8M | $9.7M | ||
| Q2 25 | $9.6M | $9.8M | ||
| Q1 25 | $9.4M | $10.1M | ||
| Q4 24 | $7.4M | $9.6M | ||
| Q3 24 | $6.8M | $9.5M | ||
| Q2 24 | $8.5M | $9.9M | ||
| Q1 24 | $5.8M | $9.4M |
净利润ASMBPROV
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-9.2M | $1.7M | ||
| Q2 25 | $-10.2M | $1.6M | ||
| Q1 25 | $-8.8M | $1.9M | ||
| Q4 24 | — | $872.0K | ||
| Q3 24 | $-9.6M | $1.9M | ||
| Q2 24 | $-11.2M | $2.0M | ||
| Q1 24 | $-9.1M | $1.5M |
营业利润率ASMBPROV
| Q4 25 | — | 20.8% | ||
| Q3 25 | -100.9% | 28.1% | ||
| Q2 25 | -115.2% | 23.6% | ||
| Q1 25 | -105.5% | 26.2% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | -160.1% | 28.3% | ||
| Q2 24 | -143.0% | 27.8% | ||
| Q1 24 | -185.5% | 22.5% |
净利率ASMBPROV
| Q4 25 | — | 14.6% | ||
| Q3 25 | -85.2% | 17.3% | ||
| Q2 25 | -105.9% | 16.7% | ||
| Q1 25 | -93.6% | 18.4% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | -140.4% | 20.0% | ||
| Q2 24 | -130.7% | 19.7% | ||
| Q1 24 | -156.9% | 15.9% |
每股收益（稀释后）ASMBPROV
| Q4 25 | — | $0.22 | ||
| Q3 25 | $-0.72 | $0.25 | ||
| Q2 25 | $-1.33 | $0.24 | ||
| Q1 25 | $-1.17 | $0.28 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | $-1.51 | $0.28 | ||
| Q2 24 | $-1.98 | $0.28 | ||
| Q1 24 | $-1.66 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $54.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $127.5M |
| 总资产 | $240.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBPROV
| Q4 25 | — | $54.4M | ||
| Q3 25 | $22.5M | $49.4M | ||
| Q2 25 | $24.0M | $53.1M | ||
| Q1 25 | $23.4M | $50.9M | ||
| Q4 24 | $38.3M | $45.5M | ||
| Q3 24 | $28.5M | $48.2M | ||
| Q2 24 | $19.2M | $51.4M | ||
| Q1 24 | $18.7M | $51.7M |
股东权益ASMBPROV
| Q4 25 | — | $127.5M | ||
| Q3 25 | $182.7M | $128.4M | ||
| Q2 25 | $18.1M | $128.5M | ||
| Q1 25 | $27.1M | $128.9M | ||
| Q4 24 | $33.4M | $128.6M | ||
| Q3 24 | $26.0M | $129.6M | ||
| Q2 24 | $34.7M | $129.9M | ||
| Q1 24 | $32.6M | $129.5M |
总资产ASMBPROV
| Q4 25 | — | $1.2B | ||
| Q3 25 | $240.0M | $1.2B | ||
| Q2 25 | $80.8M | $1.2B | ||
| Q1 25 | $99.0M | $1.3B | ||
| Q4 24 | $119.2M | $1.3B | ||
| Q3 24 | $100.3M | $1.3B | ||
| Q2 24 | $115.3M | $1.3B | ||
| Q1 24 | $119.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $1.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $1.0M |
| 自由现金流率自由现金流/营收 | -140.7% | 10.5% |
| 资本支出强度资本支出/营收 | 0.4% | 1.9% |
| 现金转化率经营现金流/净利润 | — | 0.85× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流ASMBPROV
| Q4 25 | — | $1.2M | ||
| Q3 25 | $-15.1M | $2.5M | ||
| Q2 25 | $-16.8M | $8.7M | ||
| Q1 25 | $-23.4M | $3.3M | ||
| Q4 24 | $-51.1M | $324.0K | ||
| Q3 24 | $-15.2M | $2.6M | ||
| Q2 24 | $-17.1M | $5.7M | ||
| Q1 24 | $-18.4M | $3.0M |
自由现金流ASMBPROV
| Q4 25 | — | $1.0M | ||
| Q3 25 | $-15.2M | $2.5M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | $-51.1M | $307.0K | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | $-17.1M | $4.1M | ||
| Q1 24 | $-18.4M | $2.6M |
自由现金流率ASMBPROV
| Q4 25 | — | 10.5% | ||
| Q3 25 | -140.7% | 25.2% | ||
| Q2 25 | — | 83.5% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | -695.2% | 3.2% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | -200.6% | 41.3% | ||
| Q1 24 | -317.7% | 27.5% |
资本支出强度ASMBPROV
| Q4 25 | — | 1.9% | ||
| Q3 25 | 0.4% | 0.5% | ||
| Q2 25 | 0.0% | 5.4% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.0% | 1.8% | ||
| Q2 24 | 0.2% | 16.0% | ||
| Q1 24 | 0.2% | 4.2% |
现金转化率ASMBPROV
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 5.34× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 2.91× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
